144 Ventures Invests in ImpacFat — To Advance Cultivated Omega-3 Fish Fat Innovation

Japan, 1 October 2025 – 144 Ventures (“144 Ventures”), the Singapore-based pre-seed investment arm of the Leave a Nest Co., Ltd. Group, is proud to announce its investment into ImpacFat Pte. Ltd. (“ImpacFat”), a pioneer in stem-cell-based omega-3 fish fat technologies. The announcement was made at a press event held at the LiSH (Link Scholars’ Hub) Studio 1, TAKANAWA GATEWAY CITY in Tokyo on 1 October 2025, where the Managing Director of 144 Ventures formally signed the investment on behalf of 144 Ventures.

Key Highlights

• ImpacFat is the world’s first company to commercialise stem-cell-derived fish fat rich in omega-3 fatty acids, offering a more sustainable and scalable alternative to traditional fish oils and animal fats.

• The press event also served as the launch of the “BioGarage Initiative”, a cross-border biotech acceleration platform co-initiated by Leave a Nest and Singapore-based Esco Aster Pte. Ltd., with ImpacFat as the flagship case.

• 144 Ventures brings not only capital but also access to a network of deep-tech founders, research institutions and industry partners, aligning with its vision of supporting businesses with a “144-year” horizon for societal impact.

Quotes
“At 144 Ventures, our mission is to identify and partner with founders with bold ideas that can transform society. The name 144 itself represents 144 years, our belief that truly impactful companies must endure across generations. ” said Mr Ambrose Chia, Managing Director of 144 Ventures. “This investment is not simply financial. It is a partnership, a commitment, and a pledge. A partnership because we believe innovation cannot be achieved alone but through collaboration between founders, researchers, and society.”

“Together, we can push the boundaries of science and technology to build a more sustainable and secure future for generations to come.” Mr Chia added at the end of his speech.

About 144 Ventures
144 Ventures Pte. Ltd., based in Singapore, is the pre-seed investment arm of the Leave a Nest Group. The firm invests in visionary founders and deep-tech ventures with a long-term horizon, supporting innovations across food, agriculture, health, environment and beyond.

About ImpacFat
Founded in 2022 by a research team from Singapore’s A*STAR, ImpacFat develops cultivated fish-fat ingredients using stem-cell technology to produce omega-3 (DHA/EPA)-rich fats derived from fish species such as eel and pangasius. The company aims to supply functional ingredients for foods, supplements and cosmetics in a sustainable way.

Media Coverage:

• Strait Times: Sashimi from a lab? S’pore’s ImpacFat, a global pioneer in cultivated fish fat, launches in Japan
• Nikkei Inc